线粒体微肽MOXI通过转位至细胞核并桥接N-乙酰转移酶14与转录因子c-Jun促进纤维化基因转录
本研究探讨微肽MOXI在肾脏纤维化中的作用。MOXI在人类纤维化肾病中表达上调,与纤维化程度和肾功能丧失相关。敲除Moxi可保护小鼠免受叶酸及单侧输尿管梗阻模型的纤维化和炎症;反义MOXI寡核苷酸治疗同样有效。MOXI与Nat14及c-Jun形成复合物增强胶原I启动子活性,T49磷酸化为其核转位及复合物形成所必需。
要点
- MOXI在人类纤维化肾病中表达上调,与纤维化程度及肾功能丧失相关。
- 敲除Moxi或反义MOXI寡核苷酸治疗可保护小鼠免受纤维化和炎症。
- MOXI与Nat14及c-Jun形成复合物增强胶原I启动子活性,依赖T49磷酸化。
核心结论
- 微肽MOXI在肾脏纤维化中起关键作用,并与Nat14及c-Jun形成转录复合物。
研究设计与样本
- 研究采用人类纤维化肾病样本、培养的肾小管上皮细胞及叶酸和单侧输尿管梗阻小鼠模型,未明确报告样本量。
主要发现
- MOXI表达在人类纤维化肾病中上调,与纤维化程度和肾功能丧失相关。
- 敲除Moxi可保护小鼠免受叶酸和单侧输尿管梗阻模型的纤维化和炎症。
- 反义MOXI寡核苷酸治疗有效敲低MOXI表达并保护两种模型免受肾脏纤维化。
- MOXI与Nat14及c-Jun结合形成复合物,增强基础及TGF-β1诱导的胶原I基因启动子活性。
- T49磷酸化为MOXI核转位及与Nat14和c-Jun形成复合物所必需;MoxiT49A点突变小鼠在纤维化模型中受到保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Progressive fibrosis is a hallmark of chronic kidney disease, but we lack effective treatments to halt this destructive process. Micropeptides (peptides of no more than 100 amino acids) encoded by small open reading frames represent a new class of eukaryotic regulators. Here, we describe that the micropeptide regulator of β-oxidation (MOXI) regulates kidney fibrosis. MOXI expression was found to be up-regulated in human fibrotic kidney disease, and this correlated with the degree of fibrosis and loss of kidney function. MOXI was expressed in the cytoplasm and mitochondria of cultured tubular epithelial cells and translocated to the nucleus upon Transforming Growth Factor-β1 stimulation. Deletion of Moxi protected mice against fibrosis and inflammation in the folic acid and unilateral ureteral obstruction models. As a potential molecular therapy, treatment with an antisense MOXI oligonucleotide effectively knocked-down MOXI expression and protected against kidney fibrosis in both models. Bimolecular fluorescence complementation identified the enzyme N-acetyltransferase 14 (Nat14) and transcription factor c-Jun as MOXI binding partners. The MOXI/Nat14/c-Jun complex enhances basal and Transforming Growth Factor-β1 induced collagen I gene promoter activity. Phosphorylation at T49 is required for MOXI nuclear localization and for complex formation with Nat14 and c-Jun. Furthermore, mice with a MoxiT49A point mutation were protected in the models of kidney fibrosis. Thus, our studies demonstrate a key role for the micropeptide MOXI in kidney fibrosis and identify a new function of MOXI in forming a transcriptional complex with Nat14 and c-Jun.
引用
- Li J, Qu X, Guan C, et al. Mitochondrial micropeptide MOXI promotes fibrotic gene transcription by translocation to the nucleus and bridging N-acetyltransferase 14 with transcription factor c-Jun. Kidney Int. 2023. PMID: 36804379. doi:10.1016/j.kint.2023.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。